Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 05, 2021 01:00 ET | Source: Hyloris Pharmaceuticals

Hyloris’ Partner AFT Pharmaceuticals Signs Licensing Agreement with Aguettant for Maxigesic® IV in Eight European Markets

Hyloris’ Partner AFT Pharmaceuticals Signs Licensing Agreement with Aguettant for Maxigesic® IV in Eight European Markets Footprint across Europe now extended to a total of 20 EU member states ...
October 01, 2020 07:00 ET | Source: Hyloris Pharmaceuticals

Hyloris appoints Dr. Dietmar Aichhorn as Chief Operating Officer

Hyloris appoints Dr. Dietmar Aichhorn as Chief Operating Officer Liège, Belgium – 1 October 2020: Hyloris Pharmaceuticals SA, an innovative specialty pharmaceutical company focused on adding value to...
September 07, 2020 04:37 ET | Source: Hyloris Pharmaceuticals

Hyloris announces approval of Maxigesic® IV in eight European countries

Hyloris announces approval of Maxigesic® IV in eight European countries Commercialization of Hyloris’ second marketed product to start in early 2021 Liège, Belgium – 7 September 2020 – Hyloris...
July 07, 2020 12:31 ET | Source: Hyloris Pharmaceuticals

Mid-Stabilisation Period Announcement

Strictly Confidential NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY...
June 30, 2020 03:00 ET | Source: Hyloris Pharmaceuticals

Hyloris Pharmaceuticals: Information on the total number of voting rights and shares – additional thresholds

RESS RELEASE Information on the total number of voting rights and shares – additional thresholds Liège (Belgium), 30 June 2020, 9h00 (CEST) – regulated information – In accordance with article 15 of...
June 19, 2020 12:10 ET | Source: Hyloris Pharmaceuticals

Hyloris Pharmaceuticals Announces Coverage of the Maximum Offering Size, including Increase Option and Over-Allotment, at the Midpoint of the Price Range of its Initial Public Offering on Euronext Brussels

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, SWITZERLAND, ISRAEL, JAPAN OR SOUTH AFRICA This announcement does not constitute an...
June 18, 2020 11:03 ET | Source: Hyloris Pharmaceuticals

Hyloris Pharmaceuticals Announces the Coverage of the Base Offering Throughout the Price Range of its Initial Public Offering on Euronext Brussels

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, SWITZERLAND, ISRAEL, JAPAN OR SOUTH AFRICA This announcement does not constitute an offer to...